Silverfleet Takes on LDC Investment
London-based private equity firm Silverfleet Capital has agreed a majority investment with Aesica Pharmaceuticals replacing that of LDC. Members of Aesica’s executive team will reinvest a significant amount of money for a large minority stake. Debt is being provided by Lloyds, HSBC and Yorkshire Bank.Headquartered near Newcastle, UK, Aesica has the expertise to both develop and manufacture primary (API) and secondary stage (finished product dosage forms) pharmaceuticals.
29 September 2011•3 mins read
